Stephen Bernard, AP Business Writer
Stocks drop as jobless claims rise unexpectedly
Stocks fall after jobless claims rise, regional manufacturing report disappoints
NEW YORK (AP) — Stocks tumbled Thursday after two disappointing economic reports renewed investors’ concerns about the pace of a recovery.
The Dow Jones industrial average fell 127 points in morning trading. Broader indexes also fell more than 1 percent.
The Labor Department said claims for unemployment benefits rose unexpectedly last week and the Federal Reserve of Philadelphia said manufacturing activity in the mid-Atlantic region has dropped during August.
The disappointing reports followed news that Intel Corp. was acquiring McAfee Inc. The deal, valued at $7.68 billion, was not enough to offset the weaker economic readings.
Yesterday’s Top Performing Small Cap Stock:
Tootie Pie Company TOOT
Tootie Pie Company was a SmallCapVoice.com top performer closing up over 1% on trading volume of 8,340 shares.
Tootie Pie Company bakes and sells high-quality, handmade pies through three basic sales channels: retail, corporate and wholesale. The retail segment serves individual consumers through in-store sales, orders via telephone and internet on the Company’s website. The corporate segment serves businesses that purchase pies as a way to promote their company through client and employee appreciation programs. The wholesale segment is made up of national and regional broad line grocery and foodservice distributors who purchase pies and then resell them through their respective sales distribution channels.
Today’s SmallCapVoice.com Hot Stock to Watch:
Pro-Pointer, Inc. (Pink Sheets: PPII)
Pro Pointer, Inc., through its wholly owned subsidiary Coenzyme-A Technologies, Inc., is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the deleterious effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level.
Other Small Cap News
ImmunoGen, Inc. IMGN
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc. IMGN, a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC). Through a separate process, ImmunoGen has received a positive opinion for lorvotuzumab mertansine as an orphan medicinal product for the treatment of SCLC from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) and is awaiting final designation from the European Commission. The compound previously was granted orphan drug designation for the treatment of Merkel cell carcinoma in both the US and European Union (EU).
CDC Software Corporation CDCS
CDC Software Closes Two Seven Digit Deals in Third Quarter and Reports Increasing Sales Visibility
SHANGHAI, China & ATLANTA–(BUSINESS WIRE)–CDC Software Corporation CDCS, a global provider of hybrid enterprise software solutions and services, today announced it has closed two seven digit on-premise and software-as-a-service (SaaS) software deals so far this quarter and has seen Total Contract Backlog (TCB) increase approximately 40 percent as of July 31, 2010, compared to June 30, 2009.
Immunomedics, Inc. IMMU
Immunomedics and GE Healthcare in Research Collaboration
MORRIS PLAINS, N.J. and CHALFONT ST. GILES, UK, Aug. 18, 2010 (GLOBE NEWSWIRE) — Immunomedics, Inc. IMMU and GE Healthcare, a business unit of General Electric Company GE, announced today that they have entered into a license and collaboration agreement for the evaluation of labeling technologies based on Immunomedics’ patented F-18 peptide labeling method. Terms of the agreement were not disclosed, but GE Healthcare will fund all costs related to this collaboration.
Outdoor Channel Holdings, Inc. OUTD
Outdoor Channel Broadens Colorado Distribution Through Move to Comcast’s Digital Preferred Package
More Viewers in the Centennial State Now Have Access to America’s Leader in Outdoor TV
TEMECULA, Calif., Aug. 18 /PRNewswire-FirstCall/ — Outdoor Channel, America’s Leader in outdoor TV, today announced that the network has been moved from the Sports tier to the more broadly distributed Digital Preferred tier throughout Comcast’s cable systems in southern Colorado. Starting August 24th, more Comcast customers in Colorado Springs, Pueblo and Trinidad will have access to Outdoor Channel’s compelling line-up of hunting, fishing, shooting and adventure programming on channel 127. The transition from the Sports tier to the Digital Preferred tier allows additional subscribers in this region to catch the most thrilling outdoor line-up in the history of the network. Additionally, the network is also available to Comcast customers in southern Colorado on the HD tier.
Level 3 Communications, Inc. LVLT
Level 3 Wins Networx Contract for Social Security Administration
Social Security Administration to Use High-Speed Connectivity Solutions from Level 3 to Link Data Centers
BROOMFIELD, Colo.–(BUSINESS WIRE)–Level 3 Communications, Inc. LVLT today announced that it has signed an agreement with the Social Security Administration (SSA) to provide wavelength services under the Networx Enterprise contract program.
Under the terms of the agreement, Level 3 will provide the SSA with multiple 10 Gigabit per second (Gbps) wavelength solutions to connect several of the SSA’s data center locations with the potential to expand to additional sites in the future. Level 3’s solution is designed not only to be a cost-effective offering, but to also meet SSA’s stringent network performance, scale, capacity and usability requirements.
StemCells, Inc. STEM
StemCells, Inc. Reports Breakthrough Using Human Neural Stem Cells to Restore Motor Function in Chronic Spinal Cord Injury
Newly Published Study Shows Long-Term Reversal of Hind Limb Paralysis in Spinal Cord Injured Mice
PALO ALTO, Calif., Aug. 19, 2010 (GLOBE NEWSWIRE) — StemCells, Inc. STEM announced today the publication of new preclinical data demonstrating that the Company’s proprietary human neural stem cells restore lost motor function in mice with chronic spinal cord injury. This is the first published study to show that human neural stem cells can restore mobility even when administered at time points beyond the acute phase of trauma, suggesting the prospect of treating a much broader population of injured patients than previously demonstrated.
Digirad Corporation DRAD
Digirad Announces Medical Radiopharmaceutical Supplier Back in Service
Repair of Chalk River Reactor Should Alleviate Isotope Shortages
POWAY, CA–(Marketwire – 08/18/10) – Digirad Corporation DRAD, a diversified health care company specializing in the early detection of disease to enhance quality of life, today announced that the Canadian nuclear reactor that supplies approximately 50 percent of the medical radiopharmaceuticals to North America is back in service, thereby alleviating significant supply disruptions that negatively impacted Digirad’s DIS services business for the past 15 months with the most acute impact over the past four months.
Camtek Ltd CAMT
Camtek Receives Order for Multiple Wafer Inspection Systems
MIGDAL HAEMEK, Israel, August 19, 2010 /PRNewswire-FirstCall/ — Camtek Ltd. (NASDAQ and TASE: CAMT) (“Camtek”), announced today that it received follow-on order for multiple wafer inspection systems from a major Asian IDM (Integrated Device Maker). The systems will be installed during the third and fourth quarters of 2010.
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company’s financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.
The SmallCapVoice.com, Inc. Daily Highlights is an electronic publication, and is for informational purposes only. The Small Cap Voice Daily Highlights covers both client and non client issuers. Non client issuer’s news is listed under other small cap news. SmallCapVoice is an electronic publication providing information on selected public companies. All companies profiled on this website pay cash or restricted stock to SmallCapVoice as consideration for the electronic dissemination of the company’s information and our comments about the company. Section 17(b) of the Securities Act of 1933 requires that SmallCapVoice fully disclose the type consideration (i.e. cash, restricted stock, and restricted stock with registration rights, stock options, stock warrants, or other type consideration) and the specific amount of the consideration our company receives or will receive, directly or indirectly, from an issuer, underwriter, or dealer. No information contained in our website, e-mail communications or our publications should be considered as a solicitation to purchase or sell the securities of the profiled companies. SmallCapVoice is not a registered investment advisor or a registered securities broker dealer. We do not undertake or represent to make investment recommendations or to give advice pertaining to the purchase or sale of the securities mentioned in our web site, e-mail communications or publications. The information contained in our website, e-mail communications and publications are carefully compiled by SmallCapVoice from public sources that we believe to be reliable. SmallCapVoice, however, does not guarantee the accuracy of any information contained in our website, e-mail communications or publications. This material is not a substitute for either one’s own thorough investigation of an investment opportunity or the exercise of good business judgment. SmallCapVoice does not endorse, independently verify, or assert the truthfulness or reliability of any statements or data obtained from third party sources that are published by us about the profiled companies in our website articles, e-mail communications or publications, but we do not publish information that we know is incorrect. Investors should not rely solely on the information contained in our website, e-mail communications or publications when making investment decisions. Instead, investors should use the information provided on the profiled companies as a starting point for conducting additional research that will permit them to form their own opinions regarding the appropriateness of an investment in the profiled company’s securities. SmallCapVoice does not warrant, represent or guaranty that there has been no change in the affairs of the profiled company since the date that information was published on this website, in e-mail communications or in our publications regarding a profiled company or after the date of the profiled company’s press releases or other information disseminated via our website or publications. If you become aware of any change of circumstances related to any website article, e-mail communication or publication, please notify us immediately. See the Contact Us page for the appropriate e-mail address. The information contained in our website, e-mail communications and publications pertains to microcap, small cap and/or other thinly traded securities which by their very nature involve an extremely high degree of risk. An investment in these type of securities could result in the loss of some or all of an investment in the company. In addition, due to the illiquid nature of some of these securities, an investor may find encounter difficulties in liquidating the securities. SmallCapVoice may liquidate the stock consideration it receives at any time it deems it appropriate to do so after the required six-month holding period has run after the completion of the services for which SmallCapVoice was paid in stock. The liquidation of our stock may have a negative impact on the securities of the company liquidated, including decreased market value and/or dilution of the company’s securities. The following companies have paid, and/or have agreed to pay SmallCapVoice to: distribute the company’s information and reports on this website, to send e-mail communications; to send publications by mail, to post company Internet links on our website, and to compile and/or to distribute reports in an e-mail newsletter.
We encourage our readers to use caution when investing and educate themselves at the web sites of the Securities and Exchange Commission (“SEC”) at www.sec.gov and/or the National Association of Securities Dealers (“NASD”) at www.nasd.com. We encourage you to study the SEC’s policies regarding online newsletters at http://www.sec.gov/answers/newsltr.htm. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC’s EDGAR page. The NASD has published information on how to invest carefully at its web site. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our site.
Contact:
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com
Related posts
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.